<p>Disclosed is a compound represented by general formula (I) (wherein all the symbols are as defined in the description). Since the compound has excellent metabolic stability and is capable of avoiding hepatotoxicity or the like, while having Btk-selective inhibitory activity, the compound can form a safe therapeutic agent for diseases associated with B cells or mast cells.</p>
申请公布号
WO2011152351(A1)
申请公布日期
2011.12.08
申请号
WO2011JP62377
申请日期
2011.05.30
申请人
ONO PHARMACEUTICAL CO., LTD.;YAMAMOTO, SHINGO;YOSHIZAWA, TOSHIO